ID   RPMI-8342
AC   CVCL_U115
SY   RPMI 8342; RPMI8342; Roswell Park Memorial Institute 8342; M-3
DR   Wikidata; Q54951270
RX   DOI=10.1093/jnci/59.2.301;
RX   PubMed=944091;
RX   PubMed=1127734;
RX   PubMed=1161259;
CC   Doubling time: 38 hours (PubMed=1127734); 62 hours (PubMed=1161259).
CC   Derived from metastatic site: Lymph node.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZY44 ! RPMI-7022
OI   CVCL_LH91 ! RPMI-7711
OI   CVCL_LH87 ! RPMI-7821
OI   CVCL_T323 ! RPMI-8252
OI   CVCL_C542 ! RPMI-8322
OI   CVCL_X375 ! RPMI-8362
OI   CVCL_X376 ! RPMI-8372
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
RX   DOI=10.1093/jnci/59.2.301;
RA   Quinn L.A., Woods L.K., Merrick S.B., Arabasz N.M., Moore G.E.;
RT   "Cytogenetic analysis of twelve human malignant melanoma cell lines.";
RL   J. Natl. Cancer Inst. 59:301-307(1977).
RX   PubMed=944091;
RA   McCulloch P.B., Dent P.B., Hayes P.R., Liao S.-K.;
RT   "Common and individually specific chromosomal characteristics of
RT   cultured human melanoma.";
RL   Cancer Res. 36:398-404(1976).
RX   PubMed=1127734; DOI=10.1093/jnci/54.5.1037;
RA   Liao S.-K., Dent P.B., McCulloch P.B.;
RT   "Characterization of human maligant melanoma cell lines. I. Morphology
RT   and growth characteristics in culture.";
RL   J. Natl. Cancer Inst. 54:1037-1044(1975).
RX   PubMed=1161259; DOI=10.1159/000225003;
RA   Gerner R.E., Kitamura H., Moore G.E.;
RT   "Studies of tumor cell lines derived from patients with malignant
RT   melanoma.";
RL   Oncology 31:31-43(1975).